| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/20/2000 | WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | WO2000003015A2 Human transport protein homologs |
| 01/20/2000 | WO2000003014A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | WO2000003001A1 Liver stem cell |
| 01/20/2000 | WO2000002923A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002905A2 Methods for accelerating bone and cartilage growth and repair |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO2000002877A2 New pharmaceutically active compounds |
| 01/20/2000 | WO2000002865A1 Pharmaceutical agents |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002859A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | WO2000002858A1 Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002841A1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002583A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002582A2 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | WO2000002579A2 Component b as angiogenic agent in combination with human growth factors |
| 01/20/2000 | WO2000002577A1 Therapeutic use of uncoupling protein hhfcw60 |
| 01/20/2000 | WO2000002574A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 01/20/2000 | WO2000002573A1 Natural composition and method for the treatment of sexual dysfunction |
| 01/20/2000 | WO2000002572A1 Inclusion of apoptotic regulators in solutions for cell storage at low temperature |
| 01/20/2000 | WO2000002568A1 Coumarin and related aromatic-based polymeric prodrugs |
| 01/20/2000 | WO2000002562A1 Compositions comprising gaba analogs and caffeine |
| 01/20/2000 | WO2000002560A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002557A1 Use of an inhibitor of cytochrome p450 optionally combined with an antifungal agent for treating mycoses |
| 01/20/2000 | WO2000002554A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | WO2000002545A2 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 01/20/2000 | WO2000002544A2 Use of piperine for treating skin pigmentation disorders |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO2000002542A2 Agents with an antidepressive effect containing pramipexol and an additional antidepressant drug |
| 01/20/2000 | WO2000002540A1 Plaster which contains steroids, and a method for the production and use thereof |
| 01/20/2000 | WO2000002455A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | WO1999058518A3 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 01/20/2000 | WO1999055672A3 Antipsychotic indolyl derivatives |
| 01/20/2000 | WO1999053943A3 Therapeutic angiogenic factors and methods for their use |
| 01/20/2000 | WO1999048858A3 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/20/2000 | WO1999026966A3 Nuclear receptor ligands and ligand binding domains |
| 01/20/2000 | WO1999021542A3 Methods for modulating macrophage proliferation using polyamine analogs |
| 01/20/2000 | WO1998042376A9 Composition comprising immunoglobulin |
| 01/20/2000 | DE19832428A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction |
| 01/20/2000 | DE19832009A1 New 2,5-disubstituted benzenesulfonyl-ureas or -thioureas, used as ATP-sensitive potassium channel blockers for treating cardiovascular disorders such as arrhythmia or cardiac insufficiency |
| 01/20/2000 | DE19831710A1 New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection |
| 01/20/2000 | CA2377178A1 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2]pyridine oral compositions |
| 01/20/2000 | CA2337795A1 Pharmaceutical agents |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2336990A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | CA2336958A1 Liver stem cell |
| 01/20/2000 | CA2336806A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | CA2336805A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | CA2336661A1 Inclusion of apoptotic regulators in solutions for cell storage at low temperature |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | CA2333923A1 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | CA2332927A1 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332344A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/19/2000 | EP0972773A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates |
| 01/19/2000 | EP0972768A1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 01/19/2000 | EP0972762A2 Novel structural analogues of vitamin D |
| 01/19/2000 | EP0972517A2 Use of 1,2,4-benzotriazine oxides for the preparation of a medicament for the treatment of tumours |
| 01/19/2000 | EP0972515A2 Cyclooxygenase Inhibitor |
| 01/19/2000 | EP0972499A2 Disposable monomer dispenser and vial breaker |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972032A2 Peptides for the treatment of systemic lupus erythematosus |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0971961A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971954A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971948A2 Inhibitors for urokinase receptor |
| 01/19/2000 | EP0971929A1 2,3-DIHYDROFURO 3,2-$i(b)]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY |
| 01/19/2000 | EP0971925A1 Pyrimidopyrimidine compounds |
| 01/19/2000 | EP0971921A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 01/19/2000 | EP0971913A1 Process for the production of semi synthetic statins via novel intermediates |
| 01/19/2000 | EP0971910A1 Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
| 01/19/2000 | EP0971909A1 Lta 4? hydrolase inhibitors |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971906A1 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids |
| 01/19/2000 | EP0971896A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |